These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6893337)

  • 21. Histological features of PUVA-induced bullae in psoriatic skin.
    McGibbon DH; Vella Briffa D
    Clin Exp Dermatol; 1978 Dec; 3(4):371-5. PubMed ID: 737881
    [No Abstract]   [Full Text] [Related]  

  • 22. Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis--enhancing properties of psoriatic serum.
    Ellis CN; Kang S; Grekin RC; Voorhees JJ; Silva J
    J Am Acad Dermatol; 1985 Sep; 13(3):437-43. PubMed ID: 4056118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of neutrophils adhesive molecules CD11b/CD18 in the course of photochemotherapy (PUVA) for psoriasis vulgaris].
    Kapuścińska R; Wysocka J; Zelazowska B; Niczyporuk W
    Pol Merkur Lekarski; 2004 Jun; 16(96):547-50. PubMed ID: 15510894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphonuclear leukocyte function in psoriasis vulgaris.
    Pease CT; Fennell M; Staughton RC; Brewerton DA
    Br J Dermatol; 1987 Aug; 117(2):161-7. PubMed ID: 3651338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic lupus erythematosus: association with psoralen--ultraviolet-A treatment of psoriasis.
    Eyanson S; Greist MC; Brandt KD; Skinner B
    Arch Dermatol; 1979 Jan; 115(1):54-6. PubMed ID: 760658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photochemotherapy (PUVA) of psoriasis using 3-carbethoxypsoralen, a non-carcinogenic compound in mice.
    Dubertret L; Averbeck D; Zajdela F; Bisagni E; Moustacchi E; Touraine R; Latarjet R
    Br J Dermatol; 1979 Oct; 101(4):379-89. PubMed ID: 389271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of in vitro PUVA on human leukocyte function.
    Bredberg A; Forsgren A
    Br J Dermatol; 1984 Aug; 111(2):159-68. PubMed ID: 6466558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Random locomotion and chemotaxis of human blood polymorphonuclear leukocytes (PMN) in the presence of EDTA: PMN in close quarters require neither leukocyte integrins nor external divalent cations.
    Malawista SE; de Boisfleury Chevance A
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11577-82. PubMed ID: 9326652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostaglandins E2, F2alpha and arachidonic acid levels in irradiated and unirradiated skin of psoriatic patients receiving PUVA treatment.
    Plummer NA; Hensby CN; Warin AP; Camp RD; Greaves MW
    Clin Exp Dermatol; 1978 Dec; 3(4):367-9. PubMed ID: 737880
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemokinetic and chemotactic factors in psoriasis scale extracts.
    Dahl MV; Lindroos WE; Nelson RD
    J Invest Dermatol; 1978 Dec; 71(6):402-6. PubMed ID: 722120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photochemotherapy: a new promising chemical derivative.
    Willis I
    Arch Dermatol Res; 1982; 272(3-4):251-6. PubMed ID: 7165333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photochemotherapy for psoriasis. A clinical cooperative study of PUVA-48 and PUVA-64.
    Arch Dermatol; 1979 May; 115(5):576-9. PubMed ID: 375839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintenance treatment for psoriasis.
    De Bersaques J
    Arch Dermatol; 1979 Sep; 115(9):1033. PubMed ID: 485172
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral methoxsalen photochemotherapy of psoriasis and mycosis fungoides.
    Parrish JA; LeVine MJ; Fitzpatrick TB
    Int J Dermatol; 1980 Sep; 19(7):379-86. PubMed ID: 6998879
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence.
    Gasparro FP
    Am J Clin Dermatol; 2000; 1(6):337-48. PubMed ID: 11702610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psoriasis: utilising the treatment options.
    Marks JM
    Drugs; 1980 Jun; 19(6):429-36. PubMed ID: 6446452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decrease in neutrophils observed in vivo in psoriatics after PUVA therapy.
    Dahl KB; Nyfors A; Brodthagen H
    Arch Dermatol Res; 1978 Jun; 262(1):131-4. PubMed ID: 686817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled study of PUVA and adjunctive topical therapy in the management of psoriasis.
    Morison WL; Parrish JA; Fitzpatrick TB
    Br J Dermatol; 1978 Feb; 98(2):125-32. PubMed ID: 629867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA repair synthesis in human skin exposed to ultraviolet radiation used in PUVA (psoralen and UV-A) therapy for psoriasis.
    Bishop SC
    Br J Dermatol; 1979 Oct; 101(4):399-405. PubMed ID: 508605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical efficacy of psoralen + sunlight vs. combination of isotretinoin and psoralen + sunlight for the treatment of chronic plaque-type psoriasis vulgaris: a randomized hospital-based study.
    Gahalaut P; Soodan PS; Mishra N; Rastogi MK; Soodan HS; Chauhan S
    Photodermatol Photoimmunol Photomed; 2014 Dec; 30(6):294-301. PubMed ID: 24828298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.